Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy

Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy

Acute myeloid leukemia (AML) is an aggressive group of cancers with high mortality rates and significant relapse risks. Current treatments are insufficient, and new therapies are needed. Recent discoveries suggest that AML may be particularly sensitive to chemotherapeutics that target mitochondria....

Full description

Bibliographic Details
Main Authors: Svetlana B. Panina, Jingqi Pei, Natalia Baran, Marina Konopleva, Natalia V. Kirienko
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Oncology
Subjects:
mitochondria-targeted drugs
mitocans
AML
leukemia treatment
targeted drug screening
synergistic drug combinations
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00435/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00435/full

Similar Items